Volition logo logo
Larger beagle image
logo-vet

Veterinarians.

An accessible and affordable blood test to aid in early detection of cancer in dogs.

Nu.Q® Vet Cancer Test

Overview

Earlier cancer detection improves outcomes.

It also improves the quality of life of the dog and its owner.

The Nu.Q® Vet Cancer Test is an affordable and accessible screening test to aid early detection. It is a simple, easy to use blood test for healthy, older dogs (7 years and older), as well as younger dogs (4 year and older) in breeds with an increased risk of developing cancer.

The Nu.Q® Vet Cancer Test is a science-backed tool that you can easily integrate into your preventive care program. It provides you with data-driven insights for a proactive care approach, to support your clinical decision making and enable you to guide pet owners with increased confidence.

Heather_Wilson_Robles & Otis
Introducing Nu.Q® Vet Cancer Test

How it works

How does the Nu.Q® Vet Cancer Test work?

What does the Nu.Q® Vet Cancer Test measure?

High cellular turnover – due to diseases like cancer – can lead to an increased concentration of nucleosomes in the bloodstream. They can be captured using antibodies tailored specifically to detect nucleosomes.

The Nu.Q® Vet Cancer Test quantifies these circulating nucleosome levels in the blood. The test needs just 0.5ml of plasma, obtainable from a 2-5ml blood draw after centrifugation.

By measuring and analyzing nucleosomes, our Nu.Q® Vet Cancer Test can help identify patients who may have a cancer. This must then be confirmed by follow-up procedures – for example, a biopsy or scan. 

Image 25-01-2024 at 11.10

What types of cancer has the Nu.Q® Vet Cancer Test been able to detect?

The Nu.Q® Vet Cancer Test can detect cancers such as lymphoma and hemangiosarcoma, even at early stages. Preliminary data suggests that this screening test can also detect some instances of Mast Cell tumours, malignant melanomas and Histiocytic Sarcoma. The current Nu.Q® Vet Cancer Test more reliably detects systemic cancers rather than soft tissue or localized cancers.

Download Nu.Q® Vet Cancer Test Technical Brochurepdf 7.58MB
Image 25-01-2024 at 11.14 (2)

How to take a sample and interpret the results

Visit our Nu.Q® Vet Cancer Test product information page for a step-by-step guide on how to take a sample from your patient and interpret the results.

Nu.Q Vet Cancer Test – Product InformationProduct Information
Veterinarian Stroking Dog Close Up
Clinical Evidence

The research behind the results

In a peer-reviewed and published case series, the Nu.Q® Vet Cancer Test was shown to detect 76% of systemic cancers.

  • 77% lymphoma
  • 82% hemangiosarcoma
  • 54% histiocytic sarcoma

Our test was able to identify approximately 50% of all cancers researched at 97% specificity.

Lymphoma is the most common form of canine cancer and together with hemangiosarcoma make up approximately one-third of all cancers.

 

Study details:

  • A total of 662 dogs were included in the study (134 healthy and 528 with cancer).
  • A variety of breeds, weights and cancer stages were represented
  • 7 cancers were evaluated: Lymphoma, Malignant melanoma, Hemangiosarcoma, Mast cell tumors, Osteosarcoma, Histiocytic sarcoma and Soft tissue sarcoma.
Clinical validation summary
0 %

of systematic cancers detected

0 %

of all cancers researched

Buy our test

Introduce Nu.Q® Vet into your clinic

Our test is currently available in the United States, Europe, Australia, and Asia through reference laboratories which include IDEXX and Heska/Antech. It is also available as an in-house test exclusively via Heska/Antech.

 

You can find details of your local distributor below.

OUR DISTRIBUTOR NETWORK
Heska Logo - Antech Company

Heska/Antech

Nu.Q® Canine Cancer Test

(USA, Europe, Asia, and Australia)

Test code: 313100
idexx revised

IDEXX

Nu.Q® Canine Cancer Screen

(USA)

Test code: 8993
NWL Mar 17

NationWide

Nu.Q® Vet Cancer Test

(UK)

 
VPG_Brandmark_Full-Colour_RGB_on-Light

Veterinary Pathology Group (VPG)

Nu.Q® Vet Cancer Test

(UK & IRL)

 
scil_animal_care_company_gmbh_germany_logo

scil animal care company

Nu.Q® Vet Cancer Test

(Europe)

 
dnatech_logo

DNA Tech

Nu.Q® Vet Cancer Test

(Portugal)

 
VetLab logo

Vetlab

Nu.Q® Vet Cancer Test

(Poland)

 
revised fuji

Fujifilm Vet Systems Co. Ltd

Nu.Q® Vet Cancer Test

(Japan)

 
Vita-Logo

Vita Genomics

Nu.Q® Vet Cancer Test

(Taiwan)

 
sage healthcare

Sage Healthcare

Nu.Q® Vet Cancer Test

(Singapore)

 
Product Resources

Brochure & Clinical Papers

vet product brochure featured

Nu.Q® Vet Cancer Test Product Brochure (US)

Media & Downloads
Hero Image

Introducing the Nu.Q® Vet Cancer Test

Videos
vet animation thumbnail

Nu.Q® Vet Cancer Test animation

Videos
A screenshot from Volition's Pet Parents outlining the value of canine cancer screening for early cancer detection in dogs and the Nu.Q® Vet Cancer Test.

Webinar series: How to use Nu.Q® Vet Cancer Test

Videos
Vet Tech brochure US thumbnail

Nu.Q® Vet Cancer Test – Technical brochure (US)…

Media & Downloads
Evaluation plasma nucloesomes dogs Wilson Robles BMC featured image

Evaluation of plasma nucleosome concentrations in dogs

Poster & Publications
how to submit a sample featured

How to submit a sample – Nu.Q® Vet Cancer Test…

Media & Downloads
fuji volition video

Volition & Fujifilm Vet Systems Launch Nu.Q® Vet Cancer…

Videos
Happy dog actively playing fetch game outdoor on sunny day

Highlights from WVC 2024

Videos

Next steps

Get in touch with our vet team

Our expert team will be on hand to offer guidance and support and to fulfil your needs.

"*" indicates required fields

Enter your contact details*
Consent*

More Information

About Nu.Q® Vet

Learn more about our Nu.Q® Vet Cancer Test

Pet Parents

Pet parents – learn more about the Nu.Q® Vet Cancer Test.